BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 7400823)

  • 21. Myasthenia gravis with anti-acetylcholine receptor antibodies.
    Meriggioli MN
    Front Neurol Neurosci; 2009; 26():94-108. PubMed ID: 19349707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)].
    Hohlfeld R; Wekerle H
    MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis.
    Vincent A; Newsom-Davis J; Newton P; Beck N
    Neurology; 1983 Oct; 33(10):1276-82. PubMed ID: 6684222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA, anti-DNA, and complement in myasthenia gravis.
    Christiansen FT; Houliston JB; Dawkins RL
    Muscle Nerve; 1978; 1(6):467-70. PubMed ID: 757869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):257-65. PubMed ID: 6813004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of antigenic sources for acetylcholine receptor antibody assays in myasthenia gravis.
    McAdams MW; Roses AD
    Ann Neurol; 1980 Jul; 8(1):61-6. PubMed ID: 6773466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-acetylcholine receptor antibody specificities in serum and in thymic cell culture supernatants from myasthenia gravis patients.
    Heidenreich F; Vincent A; Willcox N; Newsom-Davis J
    Neurology; 1988 Nov; 38(11):1784-8. PubMed ID: 3185915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thymoma Showing Elevating Anti-acetylcholine Receptor Antibody without Clinical Symptoms of Myasthenia Gravis;Report of a Case].
    Ito T; Ishizumi T; Kataba H; Saijo T; Ikeda N
    Kyobu Geka; 2018 Aug; 71(8):634-636. PubMed ID: 30185764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.
    Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N
    Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylcholine receptor antibody-producing cells in thymus and lymph nodes in myasthenia gravis.
    Fujii Y; Monden Y; Hashimoto J; Nakahara K; Kawashima Y
    Clin Immunol Immunopathol; 1985 Jan; 34(1):141-6. PubMed ID: 4038384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis.
    Penn AS; Schotland DL; Lamme S
    Muscle Nerve; 1986 Jun; 9(5):407-15. PubMed ID: 3724787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange.
    Newsom-Davis J; Pinching AJ; Vincent A; Wilson SG
    Neurology; 1978 Mar; 28(3):266-72. PubMed ID: 564482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA antigens and acetylcholine receptor antibody in the subclassification of myasthenia gravis in Hong Kong Chinese.
    Hawkins BR; Ip MS; Lam KS; Ma JT; Wy CL; Yeung RT; Dawkins RL
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):316-9. PubMed ID: 3958744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
    Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
    J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.
    Kuks JB; Oosterhuis HJ; Limburg PC; The TH
    J Autoimmun; 1991 Apr; 4(2):197-211. PubMed ID: 1883480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are linear AChR epitopes the real culprit in ocular myasthenia gravis?
    Wu X; Tüzün E
    Med Hypotheses; 2017 Feb; 99():26-28. PubMed ID: 28110692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma exchange in myasthenia gravis: effect on anti-AChR antibodies and other autoantibodies.
    Thorlacius S; Lefvert AK; Aarli JA; Gilhus NE; Halvorsen K; Hofstad H; Matre R; Tönder O
    Acta Neurol Scand; 1986 Dec; 74(6):486-90. PubMed ID: 3825504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial: Cause of weakness in myasthenia gravis.
    Grob D
    N Engl J Med; 1976 Mar; 294(13):722-3. PubMed ID: 1082544
    [No Abstract]   [Full Text] [Related]  

  • 39. Temporal deterioration of neurological symptoms and increase of serum acetylcholine receptor antibody levels after thymectomy: a case report of a cat with myasthenia gravis.
    Nagata N; Miyoshi T; Otake Y; Suzuki H; Kagawa Y; Yamagami T; Irie M
    J Vet Med Sci; 2017 Jan; 78(12):1893-1896. PubMed ID: 27593682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines.
    Hohlfeld R; Kalies I; Kohleisen B; Heininger K; Conti-Tronconi B; Toyka KV
    Neurology; 1986 May; 36(5):618-21. PubMed ID: 3486379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.